Literature DB >> 7655105

Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients.

T Watanabe1, T Tsuchida.   

Abstract

BACKGROUND: Lupus erythematosus (LE) is a multi-organ-system disease, the characteristics of which are reflected in the 1982 American Rheumatism Association (ARA) criteria for systemic lupus erythematosus (SLE). From a dermatological point of view, only the presence of LE-specific histopathology is necessary and sufficient for the diagnosis of LE. The association between the type of LE-specific skin lesion and the severity of extracutaneous manifestations of LE has not yet been investigated systematically.
OBJECTIVE: The aim of this study was to evaluate, according to the type of LE skin lesions, the prevalence of the 1982 criteria for SLE.
METHODS: We selected 191 patients whose skin lesions were histologically diagnosed as LE specific. Patients were classified on the basis of skin disease, and their clinical and laboratory data were analyzed.
RESULTS: Of 191 patients, 130 (68%) exhibited only one type of LE-specific skin lesion (monomorphic), 55 (29%) had two types (bimorphic) and the remaining 6 (3%) displayed three types (trimorphic). Nineteen of 22 (86%) patients who presented discoid lupus skin lesions above the neck without other eruptions were classified in the cutaneous-limited LE spectrum. Of 116 patients with acute lupus skin lesions (malar rash), 83 (72%) clearly fulfilled the 1982 ARA criteria for SLE. In skin lesions of LE profundus, chilblain lupus, subacute lupus (annular-polycyclic erythema and the papulosquamous variant), there were no significant correlations between the type of eruption and the severity of extracutaneous manifestations.
CONCLUSION: Patients with acute lupus skin lesions could usually be classified as suffering from SLE, whereas monomorphic patients with localized discoid lesions rarely exhibited extracutaneous manifestations. This tendency was less distinct in bimorphic patients. Almost all patients with subacute skin lesions were bimorphic or trimorphic, which might be due to genetic or racial differences between Japanese and other populations.

Entities:  

Mesh:

Year:  1995        PMID: 7655105     DOI: 10.1159/000246716

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

1.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Demographic and clinical characteristics of cutaneous lupus erythematosus at a paediatric dermatology referral centre.

Authors:  B Z Dickey; K E Holland; B A Drolet; S S Galbraith; V B Lyon; D H Siegel; Y E Chiu
Journal:  Br J Dermatol       Date:  2013-08       Impact factor: 9.302

3.  Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus.

Authors:  Rita Quelhas da Costa; M Elena Aguirre-Alastuey; David A Isenberg; Amanda M Saracino
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

4.  Scaly ear rash as the herald of a young girl with juvenile systemic lupus erythematosus.

Authors:  Ching-Fu Huang; Wei-Ming Wang; Chien-Ping Chiang
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

5.  Bullous systemic lupus erythematosus - a case report.

Authors:  Eduardo Messias Hirano Padrão; Lucas Faria Teixeira; Celina Wakisaka Maruta; Valéria Aoki; Aloisio Souza Felipe da Silva; Elizabeth In Myung Kim; Luciana Avena Smelli
Journal:  Autops Case Rep       Date:  2019-02-25

Review 6.  The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review.

Authors:  Srita Chakka; Rebecca L Krain; Josef Symon S Concha; Benjamin F Chong; Joseph F Merola; Victoria P Werth
Journal:  Ann Transl Med       Date:  2021-03

7.  Interventions for cutaneous disease in systemic lupus erythematosus.

Authors:  Cora W Hannon; Collette McCourt; Hermenio C Lima; Suephy Chen; Cathy Bennett
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09

8.  Autologous fat transfer in a patient with lupus erythematosus profundus.

Authors:  Jimi Yoon; Hwa Mi Kim; Tae-Heung Kim; Chung-Won Kim; Young-Woo Sun; Tae-Jin Yoon
Journal:  Case Rep Dermatol       Date:  2012-10-09

9.  Immunohistochemical Analysis of Interleukin-17 Producing T Helper Cells and Regulatory T Cells Infiltration in Annular Erythema Associated with Sjögren's Syndrome.

Authors:  Saori Itoi; Atsushi Tanemura; Mamori Tani; Shun Kitaba; Mika Terao; Hiroyuki Murota; Naoki Oiso; Ichiro Katayama
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444

Review 10.  Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.

Authors:  Chrissy Bolton; Yifan Chen; Rachel Hawthorne; Ianthe R M Schepel; Elinor Harriss; Silke C Hofmann; Spencer Ellis; Alexander Clarke; Helena Wace; Blanca Martin; Joel Smith
Journal:  Drugs R D       Date:  2020-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.